Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.

Metadata

Provider:

Business Wire, Inc.

Retrieved on:

Monday, August 10, 2020

Information

Tags:

Biotechnology, Hospitals, Health, Genetics, Pharmaceutical, Branches of biology, Biology, Life sciences, Sangamo Therapeutics, Genetic engineering, Gene therapy, Genome editing

Geotags:

California, United States

⚠ generated by AI ↴

Summary

Key Points:

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation.
For more information about Sangamo, visit www.sangamo.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005105/en/

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005105/en/